GGS
SHC icon

Galvin Gaustad & Stein’s Sotera Health SHC Stock Holding History

Galvin Gaustad & Stein’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,107
Closed -$417K – 278
2026
Q1 		$417K Buy
29,107
+4,655
+19% +$77.3K 0.03% 185
2025
Q4 		$431K Buy
24,452
+6,941
+40% +$115K 0.03% 176
2025
Q3 		$275K Buy
17,511
+6,457
+58% +$90.7K 0.02% 180
2025
Q2 		$123K Buy
+11,054
New +$129K 0.01% 190

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Galvin Gaustad & Stein's SHC Position: Q2 2026 in Review

Galvin Gaustad & Stein sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 29,107 shares — an estimated $417K sold.

Galvin Gaustad & Stein first reported a position in SHC in Q2 2025 and held it in 4 quarters. The position peaked at $431K in Q4 2025. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Galvin Gaustad & Stein reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
  • Galvin Gaustad & Stein sold 29,107 Sotera Health shares in Q2 2026, an estimated $417K.
  • Galvin Gaustad & Stein first reported a position in Sotera Health in Q2 2025 and held it in 4 quarters.
  • Galvin Gaustad & Stein's Sotera Health position peaked at $431K in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q2 2026, filed 29 Jul 2026.